Company profile
2N Pharma company profile
2N Pharma aims to give people with brain diseases new treatment options and renewed hope. The company develops novel, small molecule, disease-modifying drugs with initial focus on ALS and Parkinson's. 2N Pharma has received funding from the Novo Nordisk Foundation (through the BioInnovation Institute), the US Department of Defense (CDMRP/ALSRP), Danish Growth Fund, and Innovation Fund Denmark. The company is based on published scientific work led by co-founder and CSO, Dr John Nieland.
Business identity
- Website
- https://2npharma.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2019-01-01
Headquarters
- Headquarters
- Aalborg, North Denmark, Denmark
- Postal code
- 9220
- Country code
- DK
- Continent
- Europe